| Sherri Lynn Turner, INTERN | |
|
469 N 200 E, Lindon, UT 84042-1421 | |
| (801) 400-1897 | |
| Not Available |
| Full Name | Sherri Lynn Turner |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 469 N 200 E, Lindon, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194073973 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sherri Lynn Turner, INTERN 469 N 200 E, Lindon, UT 84042-1421 Ph: (801) 400-1897 | Sherri Lynn Turner, INTERN 469 N 200 E, Lindon, UT 84042-1421 Ph: (801) 400-1897 |
News Archive
Reporting for Kaiser Health News, Arlene Weintraub writes: "In the increasingly tense wrangling between the insurance industry and state regulators over the definition of what spending can qualify as medical care under the new health law, one of the loudest lobbying voices is a relatively small player: Cigna Corp" (Weintraub, 8/16).
Advaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectious diseases, will update preliminary data on the safety and clinical benefit of ADXS-HPV from an ongoing randomized Phase 2 trial of ADXS-HPV with or without cisplatin in Indian women with recurrent/refractory cervical cancer who have failed cytotoxic therapy in a poster titled "ADXS11-001 immunotherapy targeting HPV-E7: Preliminary survival data from a phase II study in Indian women with recurrent/refractory cervical cancer" at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, on Sunday, June 3, 2012.
While news emerges regarding Tenet's plan to acqure Vanguard Health for $1.73 billion, the Ford Motor Co. announces its plans to launch a two-year health management program.
Patients who underwent endoscopic testing prior to surgery for lung cancer had significantly better quality of life at the end of the staging process, with no significant difference in costs between the two strategies, according to data presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.
› Verified 1 days ago
Valerie R Ross, LCMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2578 W 600 N Ste 102, Lindon, UT 84042 Phone: 385-220-0770 | |
Richard Bishop, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 N Anderson Ln, Lindon, UT 84042 Phone: 801-310-6880 | |
Monique Norman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 North Anderson Lane, Lindon, UT 84042 Phone: 801-310-6880 | |
Sarah Law, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 N Anderson Ln, Lindon, UT 84042 Phone: 801-310-6880 | |
Mr. Tracy Lane Fuchs, CMHC, ASUDC Counselor Medicare: Not Enrolled in Medicare Practice Location: 145 S 200 E, Lindon, UT 84042 Phone: 801-784-9455 Fax: 888-876-2112 | |
Leimoni Feinga, Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 N Anderson Ln, Lindon, UT 84042 Phone: 801-310-6880 | |
Robert Daniel Fairbanks, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 200 N Anderson Ln, Lindon, UT 84042 Phone: 801-785-1761 |